Fortrea provides clinical trial and drug development services to pharmaceutical, biotechnology and medical device companies. It last closed at $19.59 on Nov 17, down 1.01% on the day. The average 12-month price target from 7 analysts is $26.14 (+33.5% from the last close), with a high of $29.00 and a low of $22.00. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (6 buy, 1 hold, 0 sell).
Each firm's latest rating on FTRE in the past 90 days
Average 12-month target
$26.14
▲ 33.5% upside
Based on 7 analysts who set a price target on FTRE in the past 90 days. The average target is $26.14, with a high of $29.00 and a low of $22.00, compared with the last close of $19.59.
Low $22.00Avg $26.14High $29.00
Blue marker: last close $19.59
Highest target$29.00
Average target$26.14
Lowest target$22.00
Latest rating changes
TD CowenTarget raised
Nov 2Buy$23 → $26
CitigroupMaintained
Oct 30Buy$27
Truist SecuritiesTarget raised
Oct 30Buy$26 → $29
BarclaysTarget raised
Oct 30Buy$23 → $26
Evercore ISI GroupMaintained
Oct 30Buy$28
Date
Firm
Action
Rating
Price target
Nov 2
TD Cowen
Target raised
Buy
$23 → $26
Oct 30
Citigroup
Maintained
Buy
$27
Oct 30
Truist Securities
Target raised
Buy
$26 → $29
Oct 30
Barclays
Target raised
Buy
$23 → $26
Oct 30
Evercore ISI Group
Maintained
Buy
$28
Loading…
Technical Analysis
FTRE · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock is 12% below its 20 day and 6% below its 50 day average. It is 19% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the 100 day average at $19.57, and the nearest resistance the swing high (Aug 5) at $19.72.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 7.0%/day
Key levels
$26.1652 week high+33.5%
$21.9020 day average+11.8%
$20.8650 day average+6.5%
$20.34Pivot R1+3.8%
$19.80Pivot+1.1%
$19.72Swing high (Aug 5)+0.7%
$19.59Last close
$19.57100 day average−0.1%
$19.25Swing low (Sep 24)−1.7%
$19.06Pivot S1−2.7%
$15.93200 day average−18.7%
$8.5552 week low−56.4%
Indicators
RSI (14)
40.66
Middle of its range
Neutral
MACD
-0.39
Below its signal line
Bearish
Stochastic
13.8
Near the bottom of its range
Oversold
ADX (14)
22.4
Weak trend
Williams %R
-87.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-90.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.5%
Change over 10 sessions
Bearish
ATR (14)
$1.36
Typical daily range, 7.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumNeutral
StretchNormal
VolatilityNormal, 12.9%/day
Key levels
$26.1652 week high+33.5%
$21.9020 day average+11.8%
$20.8650 day average+6.5%
$20.34Pivot R1+3.8%
$19.80Pivot+1.1%
$19.72Swing high (Aug 5)+0.7%
$19.59Last close
$19.57100 day average−0.1%
$19.25Swing low (Sep 24)−1.7%
$19.06Pivot S1−2.7%
$15.93200 day average−18.7%
$8.5552 week low−56.4%
Indicators
RSI (14)
53.57
Middle of its range
Neutral
MACD
1.61
Below its signal line
Bearish
Stochastic
44.7
Middle of its range
Neutral
ADX (14)
35.9
Trending up
Williams %R
-65.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
5.3
Oversold below −100, overbought above 100
Neutral
Rate of change
+13.9%
Change over 10 sessions
Bullish
ATR (14)
$2.54
Typical daily range, 12.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for FTRE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how FTRE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow FTRE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How FTRE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FTRE is in one of them and how their past FTRE trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Fortrea Holdings
Fortrea is a contract research organization based in Durham, North Carolina. It provides clinical trial and development services to pharmaceutical, biotechnology and medical device companies. Its offerings include clinical pharmacology studies, full clinical development from early phase through trials after approval, and consulting on product development, regulatory strategy and market access. Customers can choose full service, functional service provider or hybrid delivery models.